Pilot, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Acne Vulgaris Patients.

Trial Profile

Pilot, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Acne Vulgaris Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 May 2016

At a glance

  • Drugs Minocycline (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2016 Results published in a Foamix Pharmaceuticals media release.
    • 11 Jun 2013 Results reported in a Foamix media release.
    • 06 Jun 2013 Primary endpoint 'Lesion-healing' has been met, according to a Foamix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top